ArticleProceedings of the National Academy of Sciences of the United States of America2022

CRY2 isoform selectivity of a circadian clock modulator with antiglioblastoma efficacy.

Simon Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.